Detalhe da pesquisa
1.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Oncologist
; 28(2): 139-148, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36367377
2.
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.
BMC Med Res Methodol
; 23(1): 36, 2023 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36765307
3.
Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial.
Qual Life Res
; 32(3): 669-679, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36115002
4.
Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.
Qual Life Res
; 31(5): 1359-1370, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34817733
5.
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 256-266, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33476595
6.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(5): 702-715, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33862000
7.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med
; 379(25): 2395-2406, 2018 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30575490
8.
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.
Qual Life Res
; 30(1): 91-103, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32809099
9.
Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
Int J Cancer
; 145(11): 3163-3172, 2019 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31107542
10.
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4).
Oncology
; 93(6): 367-376, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28982109
11.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Lancet Oncol
; 15(3): 305-14, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24556041
12.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.
Eur J Cancer
; 186: 151-165, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37068407
13.
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.
Cancers (Basel)
; 14(20)2022 Oct 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36291851
14.
Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.
Semin Oncol
; 48(1): 69-75, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33714591
15.
Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03.
Oncotarget
; 8(31): 51830-51839, 2017 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28881692
16.
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial.
Med Decis Making
; 36(5): 615-28, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26683246
17.
Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.
Radiother Oncol
; 115(2): 246-52, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25921382
18.
Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy.
Radiother Oncol
; 110(1): 144-9, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24418359
19.
Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial.
Dig Liver Dis
; 46(10): 950-5, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25027552
20.
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.
J Clin Oncol
; 30(36): 4558-65, 2012 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23109696